Canada Markets closed

Replimune Group, Inc. (REPL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.58-0.06 (-0.18%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close32.64
Bid30.00 x 800
Ask33.50 x 800
Day's Range31.99 - 33.97
52 Week Range20.40 - 54.85
Avg. Volume283,150
Market Cap1.519B
Beta (5Y Monthly)2.50
PE Ratio (TTM)N/A
EPS (TTM)-1.75
Earnings DateAug. 05, 2021 - Aug. 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est55.22
  • Simply Wall St.

    We're Not Worried About Replimune Group's (NASDAQ:REPL) Cash Burn

    We can readily understand why investors are attracted to unprofitable companies. For example, although...

  • GlobeNewswire

    Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update

    Updated complete and durable response data in RP1 (vusolimogene oderparepvec) skin cancer cohorts support the ongoing registration directed development programs in CSCC and anti-PD-1 failed melanoma, with full accrual for both programs expected in mid-2022 Initial data with RP2 as monotherapy and in combination with Opdivo® (nivolumab) in patients with difficult-to-treat and anti-PD-1 failed cancers supports expanding the Phase 1 clinical trial to focus on patients whose tumors have metastasized

  • GlobeNewswire

    Replimune to Present at Two Upcoming Investor Conferences

    WOBURN, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, today announced that members from the Replimune management team will present and host investor meetings at the following two conferences: BTIG Virtual Biotechnology Conference 2021Date: Monday, August 9, 2021Presentation Time: 11:00 am ET 2021 Wedbush PacGrow Healthcare Virtual ConferencePanel: For Your IOn